Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

129 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Severity and organ distribution of chronic graft-versus-host disease with posttransplant cyclophosphamide-based versus methotrexate/calcineurin inhibitor-based allogeneic hematopoietic cell transplantation.
Chhabra S, Jerkins JH, Monahan K, Szabo A, Shah NN, Abedin S, Runaas L, Fenske TS, Pasquini MC, Shaw BE, Drobyski WR, Saber W, D'Souza A, Dhakal B, Mohan M, Longo W, Hamadani M. Chhabra S, et al. Among authors: drobyski wr. Bone Marrow Transplant. 2024 Mar;59(3):373-379. doi: 10.1038/s41409-023-02178-y. Epub 2024 Jan 4. Bone Marrow Transplant. 2024. PMID: 38177221
Widening demographic gaps in CAR-T therapy utilization for multiple myeloma in the United States.
Lin M, Estrada-Merly N, Eapen M, Zamora AE, Pezzin LE, Winn AN, Philip J, Schinke C, Drobyski WR, Anderson LD Jr, D'Souza A. Lin M, et al. Among authors: drobyski wr. Bone Marrow Transplant. 2023 Dec;58(12):1400-1402. doi: 10.1038/s41409-023-02102-4. Epub 2023 Sep 6. Bone Marrow Transplant. 2023. PMID: 37673983 Free PMC article. No abstract available.
Corrigendum to 'Ixazomib for chronic Graft-Versus-Host Disease prophylaxis following allogeneic hematopoietic cell transplantation' [Biology of Blood and Marrow Transplantation 26/10 (2020) 1876-1885].
Chhabra S, Visotcky A, Pasquini MC, Zhu F, Tang X, Zhang MJ, Thompson R, Abedin S, D'Souza A, Dhakal B, Drobyski WR, Fenske TS, Jerkins JH, Rizzo JD, Runaas L, Saber W, Shah NN, Shaw BE, Horowitz MM, Hari PN, Hamadani M. Chhabra S, et al. Among authors: drobyski wr. Transplant Cell Ther. 2022 Oct;28(10):717. doi: 10.1016/j.jtct.2021.01.005. Epub 2021 Jan 10. Transplant Cell Ther. 2022. PMID: 36202527 Free article. No abstract available.
Mitigation of gastrointestinal graft-versus-host disease with tocilizumab prophylaxis is accompanied by preservation of microbial diversity and attenuation of enterococcal domination.
Chhabra S, Szabo A, Clurman A, McShane K, Waters N, Eastwood D, Samanas L, Fei T, Armijo G, Abedin S, Longo W, Hari P, Hamadani M, Shah NN, Runaas L, Jerkins JH, Van den Brink M, Peled JU, Drobyski WR. Chhabra S, et al. Among authors: drobyski wr. Haematologica. 2023 Jan 1;108(1):250-256. doi: 10.3324/haematol.2022.281309. Haematologica. 2023. PMID: 36106394 Free PMC article. No abstract available.
129 results